Posted on August 4, 2022
Register for our ET Virtual Education Conference, Learn about Surgical Treatments for ET, Help Find a Cure for Essential Tremor
Categories: Tremor Gram
Register for our ET Virtual Education Conference, Learn about Surgical Treatments for ET, Help Find a Cure for Essential Tremor
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for major depressive disorder (MDD), postpartum depression (PPD) and other psychiatric disorders and SAGE-324 for essential tremor and other neurological disorders.